The affiliation between the UAB O’Neal Comprehensive Cancer Center and Infirmary Cancer Care will convey NCI-designated complete most cancers care to the Gulf Coast area for the primary time. The UAB Health System and Infirmary Health have entered a relationship to convey collaborative, complete most cancers providers to sufferers in southern Alabama, southeast Mississippi and the Florida panhandle. The results of a multi-year planning effort on behalf of the management of the 2 organizations, this partnership was born with the purpose of lowering the burden of most cancers, enhancing outcomes, and increasing most cancers scientific discovery by means of an elevated footprint and sources of each organizations.

“As Infirmary Health developed its cancer program, Infirmary Cancer Care, we wanted to have a meaningful and care-altering partnership that would enable us to continue to offer the highest level of care for our patients,” mentioned Mark Nix, president and CEO of Infirmary Health. “Collaboration and affiliation with the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, one of the few National Cancer Institute-designated comprehensive cancer centers in the country, makes this goal possible, and we are confident our collaborative future with UAB will further our organization’s vision of being the first choice for health care in our region.”

With the O’Neal Comprehensive Cancer Center at UAB serving as the one National Cancer Institute-designated complete most cancers heart in Alabama and Infirmary Health as the biggest built-in well being system in south Alabama and alongside the central Gulf Coast, the mixing of experience, sources and providers between the 2 organizations will foster collaboration in scientific care, primary translational care providers, prevention and early most cancers detection amongst current and new sufferers.

“At UAB, our mission is to strive to offer an NCI-designated level of cancer care to anyone with cancer in the state of Alabama and bordering states, and this new partnership enables us to do just that,” mentioned Barry Sleckman, M.D., Ph.D., director of the O’Neal Comprehensive Cancer Center at UAB. “Partnering with Infirmary Cancer Care allows us to extend our impact and provide our expertise to a broader patient population and to expand access to cancer clinical trials while allowing patients to remain close to home. Their knowledge of the local health care landscape will be invaluable as we jointly serve patients in the region.”

Patients will proceed to obtain care at Infirmary Cancer Care’s 5 areas in Mobile and Baldwin counties however will now have entry to the experience of most cancers specialists and multidisciplinary groups at UAB, opening the door for expanded remedy choices, most notably scientific trials.

While collaborating carefully, each organizations will present scientific providers below their current licenses and authorized entities. There isn’t any change in possession because of this partnership.

For each the UAB Health System and the O’Neal Comprehensive Cancer Center at UAB, this partnership furthers the enterprise’s dedication to offering the very best degree of care potential for all Alabamians and for individuals who search medical providers from UAB Medicine.

“Partnering with Infirmary Health in this capacity allows us the ability to extend our impact statewide, which is paramount to our mission here at UAB Medicine,” mentioned Dawn Bulgarella, CEO of the UAB Health System. “We look forward to a prosperous, collaborative partnership with Infirmary Health and together continuing to enhance the level of cancer care that patients have access to in our state.”

“This partnership is monumental for health care in Alabama and the cancer patients of our region,” mentioned Furhan Yunus, M.D., director of Infirmary Cancer Care. “Through our collaboration, Infirmary Cancer Care patients will now have access to more than 200 clinical trials and the resources of an NCI-designated comprehensive cancer center close to home. This will improve not only the outcomes for our patients but also their quality of life during their cancer treatment and beyond.”